Immunological Consequences of Lenalidomide with and without Dexamethasone in Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Kloeber, Jake A. [1 ]
Kimlinger, Teresa K. [2 ]
Haug, Jessica L. [2 ]
Henderson, Kimberly J. [2 ]
Rajkumar, S. Vincent [2 ]
Kumar, Shaji K. [2 ]
机构：
[1] Mayo Clin, Med Scientist Training Program, Coll Med & Sci, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128335
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3070
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide
    Kobayashi, Takahiro
    Miura, Masatomo
    Niioka, Takenori
    Fujioka, Yuki
    Abumiya, Maiko
    Yoshioka, Tomoko
    Kameoka, Yoshihiro
    Nishikawa, Hiroyoshi
    Takahashi, Naoto
    BLOOD, 2017, 130
  • [22] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma
    Gay, Francesca
    Hayman, Suzanne
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russel, Stephen
    Roj, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    BLOOD, 2009, 114 (22) : 1494 - 1495
  • [23] A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
    Derman, Ben A.
    Major, Ajay
    Rosenblatt, Jacalyn
    Avigan, David
    Rampurwala, Murtuza M.
    Alcantar, Luis
    Libao, Bernadette M.
    McIver, Amanda
    Andreatos, Evangelia
    Major, Sarah
    Wolfe, Brittany
    Gorski, Martha
    Karrison, Theodore G.
    Stefka, Andrew
    Jakubowiak, Andrzej
    BLOOD, 2021, 138
  • [24] Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
    Facon, Thierry
    Venner, Christopher P.
    Bahlis, Nizar J.
    Offner, Fritz
    White, Darrell J.
    Karlin, Lionel
    Benboubker, Lotfi
    Rigaudeau, Sophie
    Rodon, Philippe
    Voog, Eric
    Yoon, Sung-Soo
    Suzuki, Kenshi
    Shibayama, Hirohiko
    Zhang, Xiaoquan
    Twumasi-Ankrah, Philip
    Yung, Godwin
    Rifkin, Robert M.
    Moreau, Philippe
    Lonial, Sagar
    Kumar, Shaji K.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    BLOOD, 2021, 137 (26) : 3616 - 3628
  • [25] Selinexor combined with bortezomib, lenalidomide, and dexamethasone for the treatment of newly diagnosed multiple myeloma with extramedullary disease
    Yin, Junjing
    Zhou, Xia
    Li, Xuemei
    Yuan, Chenglu
    Chu, Xiaoxia
    Hao, Lumei
    Wu, Hongying
    Zhong, Yuping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) vs daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Tan, Carlyn Rose
    Maclachlan, Kylee
    Nemirovsky, David
    Derkach, Andriy
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi
    Patel, Dhwani
    Shekarkhand, Tala
    Rueda, Colin
    Lahoud, Oscar
    Shah, Gunjan
    Scordo, Michael
    Chung, David
    Landau, Heather
    Giralt, Sergio
    Usmani, Saad
    Lesokhin, Alexander
    Korde, Neha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S127 - S127
  • [27] STEM CELL MOBILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA FOLLOWING THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE
    Kumar, S.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Dingli, D.
    Miceli, T.
    Litzow, M. R.
    Rajkumar, S. V.
    Gertz, M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 66 - 66
  • [28] Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
    Palumbo, Antonio
    Hajek, Roman
    Delforge, Michel
    Kropff, Martin
    Petrucci, Maria Teresa
    Catalano, John
    Gisslinger, Heinz
    Wiktor-Jedrzejczak, Wieslaw
    Zodelava, Mamia
    Weisel, Katja
    Cascavilla, Nicola
    Iosava, Genadi
    Cavo, Michele
    Kloczko, Janusz
    Blade, Joan
    Beksac, Meral
    Spicka, Ivan
    Plesner, Torben
    Radke, Joergen
    Langer, Christian
    Ben Yehuda, Dina
    Corso, Alessandro
    Herbein, Lindsay
    Yu, Zhinuan
    Mei, Jay
    Jacques, Christian
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19): : 1759 - 1769
  • [29] Lenalidomide: The optimal choice in newly diagnosed multiple myeloma
    Palumbo, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 271 - 271
  • [30] Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
    McCaughan, Georgia J.
    Gandolfi, Sara
    Moore, John J.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (02) : 190 - 204
12345